Haematological disorders

Applied filters

Haematological disorders

COVID-19 Medicines Optimisation (1)
- COVID-19 Medicines Optimisation: Specialty Guidance (1)
COVID-19 Vaccines (1)
- General information and guidance (1)
  - All vaccines: Answers to Questions (1)
Care Setting (1)
- Trusts (1)
Events (1)
- Past Event (1)
- Webinars (1)
Guidance (89)
- Administering (1)
- Advanced therapy medicinal products (11)
- Cautions and contraindications (1)
- Dosing (2)
- Safety in Breastfeeding (51)
- Safety in Pregnancy (1)
- Stability in dosette boxes (40)
- Stability outside the fridge (23)
Medicine (114)
- Agalsidase alfa (1)
- Albumin human (1)
- Alfacalcidol (1)
- Alglucosidase alfa (1)
- Aluminium hydroxide (1)
- Anagrelide (1)
- Andexanet alfa (1)
- Apixaban (1)
- Ascorbic acid (1)
- Calcitriol (1)
- Calcium acetate (1)
- Calcium carbonate (1)
- Calcium polystyrene sulfonate (1)
- Carglumic acid (1)
- Carnitine (1)
- Celiprolol (1)
- Cinacalcet (1)
- Colecalciferol (1)
- Crizanlizumab (1)
- Cyanocobalamin (2)
- Dabigatran etexilate (1)
- Dalteparin (3)
- Darbepoetin alfa (1)
- Deferasirox (1)
- Deferiprone (1)
- Eculizumab (1)
- Edoxaban (1)
- Eftrenonacog alfa (1)
- Eltrombopag (1)
- Emicizumab (1)
- Enoxaparin (3)
- Epoetin alfa (2)
- Epoetin beta (2)
- Epoetin zeta (1)
- Ergocalciferol (1)
- Factor VIII + von Willebrand factor (1)
- Fedratinib (1)
- Ferric carboxymaltose (1)
- Ferrous fumarate (1)
- Ferrous gluconate (1)
- Ferrous sulfate (1)
- Ferumoxytol (1)
- Fibrinogen (1)
- Fibrinogen + Thrombin (1)
- Filgrastim (1)
- Folic acid (1)
- Fostamatinib (1)
- Galsulfase (1)
- Haem arginate (1)
- Hydroxocobalamin (3)
- Hydroxycarbamide (1)
- Idarucizumab (1)
- Idursulfase (1)
- Imiglucerase (1)
- Iron dextran (1)
- Iron isomaltoside 1000 (1)
- Iron sucrose (1)
- Lanthanum carbonate (1)
- Laronidase (1)
- Lenograstim (1)
- Lipegfilgrastim (1)
- Magnesium sulfate (1)
- Menadiol (1)
- Mercaptamine (1)
- Methoxy polyethylene glycol-epoetin beta (1)
- Miglustat (1)
- Nicotinamide (1)
- Nitisinone (1)
- Octocog alfa (1)
- Paricalcitol (1)
- Pegfilgrastim (1)
- Penicillamine (1)
- Phosphate (1)
- Phytomenadione (1)
- Plerixafor (1)
- Polysaccharide-iron complex (1)
- Potassium chloride (1)
- Pyridoxine (1)
- Ravulizumab (1)
- Riboflavin (1)
- Rivaroxaban (1)
- Romiplostim (1)
- Ropeginterferon alfa-2b (1)
- Rurioctocog alfa pegol (1)
- Selenium (1)
- Sevelamer (1)
- Simoctocog alfa (1)
- Simvastatin + Ezetimibe (1)
- Sodium bicarbonate (1)
- Sodium chloride (1)
- Sodium phenylbutyrate (1)
- Thiamine (1)
- Tinzaparin (3)
- Trientine (1)
- Turoctocog alfa (2)
- Velaglucerase alfa (1)
- Warfarin (1)
- Zinc (1)
- Zinc acetate (1)
- von Willebrand factor (1)
Planning (85)
- Biosimilars (2)
- New Medicines (66)
  - CCG commissioned new medicines (9)
  - NHS England commissioned new medicines (51)
  - Pre-registration new medicines (UK/EU) (12)
- Patent expiries (36)
Specialty (145)
- Allergy and immunology (2)
- Cancers (2)
- Cardiovascular system disorders (6)
- Ear, nose and throat disorders (2)
- Eyes and vision (5)
- Gastrointestinal disorders (2)
- Haematological disorders (145)
- Musculo-skeletal disorders (4)
- Nutritional and metabolic disorders (46)
- Obstetrics and gynaecology (1)
- Renal and urologic disorders (7)
- Respiratory disorders (2)
- Skin disorders (4)
- Surgery (3)
- Travel Medicine (1)

Inclacumab

Danicopan

Lovotibeglogene autotemcel

Summary of COVID-19 medicines guidance: Haematological disorders

19 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and haematological disorders. Our advice…